AVNS Valuation

Avanos Medical Inc

Add to Watchlist

Advanced Chart

12.010

+0.13(1.094%)1D

Overview
Forecast
Valuation
Earnings

AVNS Relative Valuation

AVNS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVNS is overvalued; if below, it's undervalued.

Historical Valuation

Avanos Medical Inc (AVNS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.08 is considered Undervalued compared with the five-year average of 21.13. The fair price of Avanos Medical Inc (AVNS) is between 11.97 to 26.45 according to relative valuation methord. Compared to the current price of 11.82 USD , Avanos Medical Inc is Undervalued By 1.24%.

Relative Value

Fair Zone

11.97-26.45

Current Price：11.82

1.24%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.65

P/B

Median3y

0.82

Median5y

1.03

20.36

FCF Yield

Median3y

6.20

Median5y

4.06

Competitors Valuation Multiple

The average P/S ratio for AVNS's competitors is 1.33, providing a benchmark for relative valuation. Avanos Medical Inc Corp (AVNS) exhibits a P/S ratio of 0.83, which is -37.65% above the industry average. Given its robust revenue growth of 0.84%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap